News About: Pharm. Industry
Pfizer Korea to move headquarters
Pfizer Korea is planning to move its headquarters from Kwangjin-gu, Seoul to a 15-story Myungdong Tower downtown in Seoul.
The company already purchased the building to meet ever-growing R&D personnel and other hum...
Levitra co-marketing with local partner in mid-July
A co-marketing of Levitra, an anti-impotence drug of Bayer, with a local business partner seems to be determined in the middle of coming July at the soonest.
Bayer said on June 23 that the co-marketing was supposed...
Hanmi Pharm 2nd in 2005 drug output
Hanmi Pharm came in second with 362.9 billion won in 2005 pharmaceutical output, according to a report released by the Korea Pharmaceutical Manufacturers Association.
The report shows that Korea's total production ...
Dong-A Pharm to conduct additional study for Zydena
Dong-A Pharm is set to additionally conduct its local clinical study to evaluate the safety and efficacy of Zydena, the first-domestically-made medication for erectile dysfunction, in patients with hypertension and di...
Yuyu Pharm advancing into health food business
Yuyu Pharm seeks to foster health foods as a new flagship business in coming years.
Toward the end, the company added Joosin BMS to its affiliate list with a 51-percent stake, to strengthen its health food business...
NGOs calling for boycott of KORUS FTA
In their joint statement on June 22, the nongovernmental organizations (NGOs) have urged the Korean government to boycott a free trade agreement (FTA) between the U.S. and Korea, claiming it threatens people's health ...
Local drug makers eye wound care adhesives market
A number of domestic pharmaceutical firms are gearing up to introduce their wound care adhesives in the hope of seizing a share of the lucrative market.
Ildong Pharm, Hyundai Pharm and Dongsung Pharm are among the ...
New antihypertensive drug to be covered by health insurance as new substance
Recently, the Health Insurance Review Agency approved a local pharmaceutical company's antihypertensive drug as a new substance and the market for antihypertension medicines dominated by a multinational giant is expec...
Iressa shows promise in advanced NSCLC
Follow-up study results show that Iressa (gefinitib) is effective in the treatment of advanced non-small cell lung cancer (NSCLC) in Korean patients, according to the Korean Cancer Study Group.
Prof. Kang Jin-hyung...
Bayer Diabetic HealthCare launches its Dream Fund program in Korea
Bayer HealthCare AG is establishing the Bayer Dream Fund program in Korea to coincide with the launch of the Breeze blood glucose monitoring system.
The Bayer Dream Fund is an annual contest designed to encourage p...
